Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3113 |
Foretinib
GSK089,EXEL-2880,GSK1363089,XL880 |
VEGFR; Tie-2; c-Met/HGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Foretinib (GSK1363089) 是多靶点酪氨酸激酶抑制剂,能够抑制 Met (IC50:0.4 nM) 和 KDR (IC50:0.9 nM)。 | |||
T71187 |
Foretinib phosphate
|
||
Foretinib phosphate is an orally bioavailable small molecule with potential antineoplastic activity. MET/VEGFR2 inhibitor GSK1363089 binds to and selectively inhibits hepatocyte growth factor (HGF) receptor c-MET and vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition of tumor angiogenesis, tumor cell proliferation and metastasis. The proto-oncogene c-MET has been found to be over-expressed in a variety of cancers. |